Stocks making the biggest moves midday: Nike, Rent-A-Center, Carnival Cruise


People walk near the entrance to Nike store, May 25, 2022 in Moscow, Russia.

Konstantin Zavrazhin | Getty Images News | Getty Images

Check out the companies making headlines in midday trading.

Nike — Nike shares dropped 12.8% after the sneaker giant said Thursday its inventory was overstocked, up 44% in its latest quarter. As a result it will offer more discounts to clear out the excess merchandise. Other retailers were also dragged down, with Lululemon Athletica and Under Armour losing almost 6% and nearly 5% respectively.

Rent-A-Center — Shares of Rent-A-Center slipped 21.6% after the company slashed its current-quarter earnings guidance, saying that economic conditions have weighed on consumer traffic and payment patterns.

Carnival Cruise — Shares of Carnival Cruise plunged 23.3% after the company forecast a loss for the fourth quarter, saying high fuel prices and inflation will delay its return to profitability. Royal Caribbean and Norwegian Cruise Lines also slipped, falling 13% and 18%, respectively.

Micron — Shares of Micron rose 1.7% after the company reported quarterly earnings that beat Wall Street expectations, even though sales fell. The chipmaker also gave a weaker-than-expected revenue outlook, saying sales are being hit by slowing consumer demand.

Charles River Laboratories — Charles River shares rose 3.6% after Jefferies upgraded the stock to buy from hold, citing the company’s potential in animal studies.

Twitter — Shares of Twitter rose 2.6% after texts between its founder, Jack Dorsey, and Elon Musk were released in court filings. The Tesla CEO is embroiled in a legal battle over his bid to buy the social media company.

Nucor — Shares of steel company Nucor jumped 1.6% after it announced plans to spend $425 million expanding a galvanized steel line at its South Carolina plant.

Amylyx Pharmaceuticals — Shares of the pharmaceutical company dropped 6.8% despite the stock rallying after hours Thursday on news of the Food and Drug Administration approving its controversial Lou Gehrig’s disease drug.

Generac — Shares of Generac gained 2.3% after Cowen initiated coverage of the company with a buy rating. The generator company is a clear industry winner and has value in its solar offering.

— CNBC’s Alex Harring and Michelle Fox contributed reporting.



Source link

Related articles

CoinShares Experiences $1.9B in Weekly Crypto Inflows, Ethereum Leads the Pack

Trusted Editorial content material, reviewed by main trade specialists and seasoned editors. Advert Disclosure The digital asset funding area maintained its upward trajectory final week, with inflows into crypto funding merchandise reaching $1.9 billion,...

Harmonic, an AI math startup co-founded by Robinhood CEO Vlad Tenev, unveils its mannequin Aristotle, saying it achieved gold medal efficiency on the 2025...

Featured Podcasts Techmeme Journey House: Tea Has Been Spilt The day's tech information, on daily basis at 5pm ET. Fifteen minutes and also you're updated. Subscribe to Techmeme Journey House. Sponsor this podcast Decoder with Nilay Patel: ChatGPT could be...

Overbought Market Meets Rising US Greenback and Tightening Liquidity

Shares completed largely decrease, with the equal-weight Invesco S&P 500® Equal Weight ETF (NYSE:) down about 60 bps, whereas the market-cap-weighted index closed flat. In the present day kicked off what needs to...

FYNXT Hires StoneX Veteran Camila Pinto as Industrial Director for UK and LATAM

Singapore-based know-how supplier for brokers FYNXT appointed Camila Pinto because the Industrial Director for the UK and LATAM. Pinto is answerable for, amongst different duties, shopper acquisition throughout the areas.“After 15 years in Monetary Companies,...

#9 – “Establishments Cannot Beat A Primary Purchase and Maintain Allocation” – Meb Faber Analysis

Pension funds’ annualized mixture returns since 2000 have been...
spot_img

Latest articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

WP2Social Auto Publish Powered By : XYZScripts.com